Cargando…
Innovative Irinotecan-Loaded Nanomicelles Will Enter Phase I Clinical Trial in 2021
Recent progress at the National Center for Nanoscience and Technology of China has enabled an extremely facile method to encapsulate irinotecan (CPT-11) into micelle-based nanoparticles (named as IH-NM). In preclinical study, compared with free CPT-11, IH-NM exhibited 1.56-fold higher maximum tolera...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454605/ https://www.ncbi.nlm.nih.gov/pubmed/34557721 http://dx.doi.org/10.1016/j.xinn.2020.100057 |